Collegium Pharmaceutical (COLL) vs Pharming Group N.V. (PHAR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Pharming Group N.V. (PHAR) has outperformed Collegium Pharmaceutical (COLL) over the past year, losing 34.2% versus a loss of 34.3%. Over five years, COLL leads with a +4.5% price change compared with +2.2% for PHAR. Collegium Pharmaceutical is the larger company by market cap ($713.9 million vs $683.0 million), about 1.0 times the size.
On valuation, Collegium Pharmaceutical trades at a lower forward P/E (3.3x vs 31.4x for Pharming Group N.V.).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | COLL | PHAR |
|---|---|---|
| Share price | $21.93 | $9.65 |
| Market cap | $713.94M | $683.01M |
| 1-day change | +0.23% | -0.31% |
| YTD return | -52.63% | -45.39% |
| 1-year return | -34.32% | -34.22% |
| 5-year return | +4.53% | +2.22% |
| P/E ratio (TTM) | 17.27 | 74.23 |
| Forward P/E | 3.30 | 31.43 |
| EPS (TTM) | $1.27 | $0.13 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $50.79 | $21.34 |
| 52-week low | $21.43 | $9.59 |
| Distance from 52-week high | -56.82% | -54.78% |
| Average volume | 743.01K | 22.88K |
| Shares outstanding | 32.56M | 70.78M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Pharming Group N.V. trades at a higher earnings multiple (74.2x vs 17.3x trailing P/E).
COLL vs PHAR FAQ
Which is bigger, Collegium Pharmaceutical or Pharming Group N.V.?
Collegium Pharmaceutical (COLL) is larger, with a market capitalization of $713.94M compared with $683.01M for Pharming Group N.V. (PHAR).
Which stock has performed better over the past year, COLL or PHAR?
PHAR returned -34.22% over the past 12 months, compared with -34.32% for COLL (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, COLL or PHAR?
COLL has the lower trailing P/E at 17.3, versus 74.2 for PHAR. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are Collegium Pharmaceutical and Pharming Group N.V. in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.